Average Co-Inventor Count = 7.85
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (11 from 1,970 patents)
2. Merck Sharp + Dohme Corp. (3 from 2,405 patents)
3. Merck Frosst Canada & Co. (1 from 76 patents)
14 patents:
1. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
2. 9394297 - Amides as pim inhibitors
3. 9085576 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
4. 8772480 - Inhibitors of PI3 kinase and/or mTOR
5. 8557830 - RAF kinase modulators and methods of use
6. 8440674 - Substituted pyrimidine compounds as RAF inhibitors and methods of use
7. 8362241 - Inhibitors of PI3 kinase and/or mTOR
8. 7989461 - Substituted quinazolinamine compounds for the treatment of cancer
9. 7928140 - Benzothiazole PI3 kinase modulators for cancer treatment
10. 7858785 - Aminopyrimidine compounds and methods of use
11. 7786132 - Aminopyrimidine compounds and methods of use
12. 7365196 - Sulphonamido-substituted bridged bicycloalkyl derivatives
13. 7049296 - Gamma-secretase inhibitors
14. 6486153 - Phenylindole derivatives as 5-HT2A receptor ligands